Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
First large-scale trial of genetically personalized treatment to start soon
April 6th, 2004
The first large-scale independent trial to study the role of molecular tumor signatures in breast cancer will get underway in the coming year, scientists announced on March 19, 2004, at the 4th European Breast Cancer Conference. TRANS-BIG, a translational research network involving about 40 partners from all over Europe and from Latin America, is in late-stage negotiation with the European Commission for funding as a Network of Excellence under the 6th Framework Research Program. Martine Piccart, MD, chair of the Breast International Group and head of the medical oncology department at the Institut Jules Bordet, Brussels, said, "The traditional...
Source: Cancer Weekly (2004-04-06)
|
